Lexicon Pharmaceuticals Announces Date Change for Second Quarter 2019 Financial Results Conference Call and Webcast to July 31, 2019

Ads

You May Also Like

Presentationer på AAPM 2016 visar på potentialen hos Elektas MR-linac

Den transformativa teknologin omnämns i 27 abstract, vilket demonstrerar det ökade intresset för MR-linac ...

Aptevo Therapeutics Collects $3.3 Million In Escrow Funds From Saol Therapeutics

SEATTLE, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology ...